Abstract
γ-Aminobutyric acid (GABA), an amino acid neurotransmitter, is widely distributed throughout the neuraxis. Two pharmacologically and molecularly distinct GABA receptors have been identified, GABAA and GABAB. GABAA receptors are pentameric ligand-gated chloride-ion channels, whereas GABAB receptors are heterodimeric G protein-coupled sites. Although GABAA receptor subtypes can display pharmacological differences, the two molecularly distinct GABAB receptors have similar substrate specificities, limiting the ability to selectively manipulate this site. Gene deletion and point mutation studies have revealed the importance of GABA receptors in neural development and function, with subtle modifications in subunit amino acid composition having profound effects on behavioral phenotype and responses to drugs. The characterization of GABAA receptors has contributed substantially to the knowledge about allosteric regulation of ligand-gated ion channels. Such information is invaluable in defining precisely the mechanisms of action of numerous drugs, such as the benzodiazepines, and toxic agents. Research on GABAB receptors has proven the existence of dimeric metabotropic receptors and has provided the chemical tools necessary for defining such systems. The characterization of the pentameric GABAA and dimeric GABAB receptors has been crucial for understanding the neurobiological basis of some nervous system disorders. Given the importance of GABA in central nervous system function, further work on its receptors is likely to yield novel therapeutics for treating a host of neurological and psychiatric conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
The GABA Receptors (1983) (Enna, S. J., ed.), Humana Press, Clifton, New Jersey, pp. 341.
Bowery, N. G., Doble, A., Hill, D. R., et al. (1981) Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals. Eur. J. Pharmacol. 71, 53–70.
The GABA Receptors (1996) (Bowery, N. G. and Enna, S. J., eds.), 2nd Ed., Humana Press, Clifton, New Jersey, pp. 332.
Kaupmann, K., Huggel, K., Heid, J., et al. (1997) Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 386, 239–246.
Jones, K. A., Borowsky, B., Tamm, J. A., et al. (1998) GABAB receptor function as a heteromeric assembly of the subunits of GABABR1 and GABABR2. Nature 396, 674–679.
Kaupmann, K., Malitschek, B., Schuler, V., et al. (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396, 683–687.
Angers, S., Salapour, A., and Bouvier, M. (2002) Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409–435.
Möhler, H., Fritschy, J. M., Crestani, F., Hensch, T., and Rudolph, U. (2004) Specific GABAA circuits in brain development and therapy. Biochem. Pharmacol. 68, 1685–1690.
Urwyler, S., Mosbacher, J., Lingenhoehl, K., et al. (2001) Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol. Pharmacol. 60, 881–884.
Barnard, E. A. (1996) The transmitter-gated channels: a range of receptor types and structures. Trends Pharmacol. Sci. 17, 305–308.
Benke, D. and Möhler, H. (2006) GABA-A receptors, in xPharm (Enna, S. J., Bylund, D. B., eds.), Elsevier, New York, http://www.xpharm.com/citation?article_ID=532. Last accessed on Jan. 3, 2007.
Payne, J. A., Rivera, C., Voipio, J., and Kaila, K. (2003) Catioin-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci. 26, 199–206.
Rivera, C., Voipio, J., and Kaila, K. (2005) Two developmental switches in GABAergic signaling: the K+-Cl− cotransporter KCC2 and carbonic anhydrase CAVII. J. Physiol. 562, 27–36.
Krnjevic, K. (2004) How does a little acronym become a big transmitter? Biochem. Pharmacol. 68, 1549–1555.
Cherubini, E., Giairsa, J. L., and Ben-Ari, Y. (1992) GABA, an excitatory transmitter in early postnatal life. Trends Neurosci. 14, 515–519.
Semyanov, A., Walker, M. C., Kullmann, D. M., and Silver, R. A. (2004) Tonically active GABAA receptors: modulating gain and maintaining the tone. Trends Neurosci. 27, 262–269.
Scimemi, A., Semyanov, A., Sperk, G., Kullmann, D. M., and Walker, M. C. (2005) Multiple and plastic receptors mediate tonic GABAA receptor currents in the hippocampus. J. Neurosci. 25, 10,016–10,024.
Adkins, C. E., Pillai, G. V., Kerby, J., et al. (2001) Alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. J. Biol. Chem. 276, 38,934–38,939.
Möhler, H., Benke, J., Benson, B., Lüscher, B., Rudolph, U., Fritschy, J. M. (1997) Diversity in structure, pharmacology, and regulation of GABAA receptors in The GABA Receptors, (Enna, S. J., and Bowery, N. G., eds.), 2nd Ed., Humana Press, Totowa, New Jersey, pp. 11–36.
Simon, J., Wakimoto, H., Fujita, N., Lalande, M., and Barnard, E. A. (2004) Analysis of the set of GABAA receptor genes in the human genome. J. Biol. Chem. 279, 41,422–41,435.
Kittler, J. T., McAinsh, K., and Moss, S. J. (2002) Mechanisms of GABAA receptor assembly and trafficking-Implications for the modulation of inhibitory neurotransmission. Mol. Neurobiol. 26, 251–268.
Lüscher, B. and Keller, C. A. (2004) Regulation of GABAA receptor trafficking, channel activity, and functional plasticity at inhibitory synapses. Pharmacol. Therap. 102, 195–221.
Nusser, Z., Sieghart, W., and Somogyi, P. (1998) Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J. Neurosci. 18, 1693–1703.
Wei, W., Zhang, N., Peng, Z., Houser, C. R., and Mody, I. (2003) Perisynaptic localization of d subunit-containing GABAA receptors and their activation by GABA spillover in the mouse dentate gyrus. J. Neurosci. 23, 10,650–10,661.
Barnard, E. A., Skolnick, P., Olsen, R. W., et al. (1998) International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291–313.
Johnston, G. A. (2002) Medicinal chemistry and molecular pharmacology of GABAc receptors. Curr. Top. Med. Chem. 2, 903–913.
Bormann, J. (2000) The ‘ABC’ of GABA receptors. Trends Pharmacol. Sci. 21, 16–19.
Wafford, K. A. and Ebert, B. (2006) Gaboxadol—a new awakening in sleep. Curr. Opin. Pharmacol. 6, 30–36.
Krogsgaard-Larsen, P., Frolund, B., Liljefors, T., and Ebert, B. (2004) GABAA agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. Biochem. Pharmacol. 68, 1573–1580.
Ebert, B., Wafford, K. A., and Deacon, S. Treating insomnia: current and investigational pharmacological approaches. Pharmacol. Therap. 12, 612–629.
Fisher, R. S. (1998) Epilepsy, in Pharmacological Management of Neurological and Psychiatric Disorders, (Enna, S. J. and Coyle, J. T., eds.), McGraw-Hill, New York, pp. 459–503.
Honmou, O., Kocsis, J. D., and Richardson, G. B. (1995) Gabapentin potentiates the conductance increase induced by nipecotic acid in CA1 pyramidal neurons in vitro. Epilepsy Res. 20, 193–202.
Bertrand, S., Ng, G. Y., Purisai, M. G., et al. (2001) The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels. J. Pharmacol. Exp. Ther. 298, 15–24.
Mortell, K. H., Anderson, D. J., Lynch, J. J. 3rd, et al. (2006) Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels. Bioorg. Med. Chem. Lett. 16, 1138–1141.
Winokur, A. (1998) Sleep disorders, in Pharmacological Management of Neurological and Psychiatric Disorders, (Enna, S. J., and Coyle, J. T., eds.), McGraw-Hill, New York, pp. 213–235.
Zorn, S. H. and Enna, S. J. (1985) The effect of mouse spinal cord transaction on the antinociceptive response to the GABA agonists THIP and baclofen. Brain Res. 338, 380–383.
Zorn, S. H. and Enna, S. J. (1985) Uptake inhibitors produce a greater antinociceptive response in the mouse tail immersion assay than other types of GABAergic drugs. Life Sci. 37, 1901–1912.
Enna, S. J. and McCarson, K. M. (2006) The role of GABA in the mediation and perception of pain. in Advances in Pharmacology, (Enna, S. J., ed.), Academic Press New York, Vol. 54, pp. 1–28.
Bowery, N. G. (1993) GABAB receptor pharmacology. Annu. Rev. Pharmacol. Toxicol. 33, 109–147.
Enna, S. J. (2001) GABA-B receptor signaling pathways, in Pharmacology of GABA and Glycine Transmission, (Möhler, H., ed.) Springer, Heidelberg, pp. 329–342.
Enna, S. J. (2001) GABA-B mystery. The search for pharmacologically distinct GABAB receptors. Mol. Interven. 1, 208–218.
Crunelli, V. and Leresche, N. (1991) A role for GABAB receptors in excitation and inhibition of thalamocortical cells. Trends Neurosci. 14, 16–21.
Wall, M. J. and Dale, N. (1994) GABAB receptors modulate an omega-conotoxin-sensitive calcium current that is required for synaptic transmission in the Xenopus embryo spinal cord. J. Neurosci. 14, 6248–6255.
Ong, J. and Kerr, D. I. (1990) GABA receptors in peripheral tissues. Life Sci. 46, 1489–1501.
Chapman, R. W., Hey, J. A., Rizzo, C. A., and Bolser, D. C. (1993) GABAB receptors in the lung. Trends Pharmacol. Sci. 14, 26–29.
Kubo, Y. and Tateyama, M. (2005) Towards a view of functioning dimeric metabotropic receptors. Curr. Opin. Neurobiol. 15, 289–295.
Margeta-Mitrovic, M., Jan, Y. N., and Jan, L. Y. (2000) A trafficking checkpoint controls GABAB receptor dimerization. Neuron 27, 97–106.
Robbins, M. J., Calver, A. R., Fillipov, A. K., Couve, A., Moss, S. J., and Pangalos, M. N. (2001) The GABAB2 subunit is essential for G protein coupling of the GABAB receptor heterodimer. J. Neurosci. 21, 8043–8052.
Gassmann, M., Shaban, H., Vigot, R., et al. (2004) Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice. J. Neurosci. 24, 6086–6097.
Bowery, N. G., Bettler, B., Froestl, W., et al. (2002) International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid (B) receptors: structure and function. Pharmacol. Res. 54, 247–264.
Möhler, H. and Fritschy, J. M. (1999) GABAB receptors make it to the top as dimmers. Trends Pharmacol. Sci. 20, 87–89.
Bonanno, G. and Raiteri, M. (1993) Multiple GABAB receptors. Trends Pharmacol. Sci. 14, 259–261.
Cunningham, M. D. and Enna, S. J. (1996) Evidence for pharmacologically distinct GABAB receptors associated with cAMP production in rat brain. Brain Res. 720, 220–224.
Yamada, K., Yu, B., and Gallagher, J. P. (1999) Different subtypes of GABAB receptors are present at pre-and postsynaptic sites within the rat dorsolateral septal nucleus. J. Neurophysiol. 81, 2875–2883.
Brauner-Osborne, H. and Krogsgaard-Larsen, P. (2000) Sequence and expression pattern of a novel orphan G-protein-coupled receptor, GPRC5B, a family C receptor with a short amino-terminal domain. Genomics 65, 121–128.
Robbins, M. J., Charles, K. J., Harrison, D. C., and Pangalos, M. N. (2002) Localization of the GPRC5B receptor in the rat brain and spinal cord. Brain Res. Mol. Brain Res. 106, 136–144.
Schuler, V., Lüscher, C., Blanchet, C., et al. (2001) Epilepsy, hyperalgesia, impaired memory, and loss of pre-and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron. 31, 47–58.
Prosser, H. M., Gill, C. H., Hirst, W. D., et al. (2001) Epileptogenesis and enhance prepulse inhibition in GABA (B1)-deficient mice. Mol. Cell. Neurosci. 17, 1059–1070.
Urwyler, S., Pozza, M. F., Lingenhoehl, K., et al. (2003) N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function. J. Pharmacol. Exp. Ther. 307, 322–330.
Couve, A., Calver, A. R., Fairfax, B., Moss, S. J., and Pangalos, M. N. (2004) Unraveling the unusual signaling properties of the GABAB receptor. Biochem. Pharmacol. 68, 1527–1536.
Sands, S. A., McCarson, K. E., and Enna, S. J. (2004) Relationship between the antinociceptive response to desipramine and changes in GABAB receptor function and subunit expression in the dorsal horn of the rat spinal cord. Biochem. Pharmacol. 67, 743–749.
Sands, S. A., McCarson, K. E., and Enna, S. J. (2003) Differential regulation of GABAB receptor subunit expression and function. J. Pharmacol. Exp. Ther. 305, 191–196.
Sands, S. A., Reisman, S. A., and Enna, S. J. (2004) Effect of antidepressants on GABAB receptor function and subunit expression in the rat hippocampus. Biochem. Pharmacol. 68, 1489–1495.
McCarson, K. E., Duric, V., Reisman, S. A., Winter, M., and Enna, S. J. (2006) GABAB receptor function and subunit expression in the rat spinal cord as indicators of stress and the antinociceptive response to antidepressants. Brain Res. 1068, 109–117.
Marshall, F. H., Jones, K. A., Kaupmann, K., and Bettler, B. (1999) GABAB receptors — the first 7TM heterodimers. Trends Pharmacol. Sci. 20, 396–399.
Lehtinen, M. J., Meri, S., and Jokiranta, T. S. (2004) Interdomain contact regions and angles between adjacent short consensus repeat domains. J. Mol. Biol. 344, 1385–1396.
Calver, A. R., Davies, C. H., and Pangalos, M. (2002) GABA(B) receptors: from monogamy to promiscuity. Neurosignals 11, 299–314.
Nehring, R. B., Horikawa, H. P., El Far, O., et al. (2000) The metabotropic GABAB receptor directly interacts with the activating transcription factor 4. J. Biol. Chem. 275, 35,185–35,191.
Vernon, E., Meyer, G., Pickard, L., et al. (2001) GABA(B) receptors couple directly to the transcription factor ATF4. Mol. Cell. Neurosci. 17, 637–645.
White, J. H., McIlhinney, R. A., Wise, A., et al. (2000) The GABAB receptor interacts directly with the related transcription factors CREB2 and ATFx. Proc. Natl. Acad. Sci. USA 97, 13,967–13,972.
Sauter, K., Grampp, T., Fritschy, J. M., et al. (2005) Subtype-selective interaction with the transcription factor CCAAT/enhancer-binding protein (C/EBP) homologous protein (CHOP) regulates cell surface expression of GABA(B) receptors. J. Biol. Chem. 280, 33,566–33,572.
Couve, A., Kittler, J. T., Uren, J. M., et al. (2001) Association of GABA(B) receptors and members of the 14-3-3 family of signaling proteins. Mol. Cell. Neurosci. 17, 317–328.
Couve, A., Restituito, S., Brandon, J. M., et al. (2004) Marlin-1, a novel RNA-binding protein associates with GABA receptors. J. Biol. Chem. 279, 13,934–13,943.
Restituito, S., Couve, A., Bawagan, H., et al. (2005) Multiple motifs regulate the trafficking of GABAB receptors at distinct checkpoints within the secretory pathway. Mol. Cell. Neurosci. 28, 747–756.
Blein, S., Ginham, R., Uhrin, D., et al. (2004) Structural analysis of the complement control protein (CCP) modules of GABAB receptor 1a: only one of the two CCP modules is compactly folded. J. Biol. Chem. 279, 48,292–48,306.
Froestl, W., Mickel, S. J., Von Sprecher, G., et al. (1995) Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists. J. Med. Chem. 38, 3313–3331.
Enna, S. J. (1997) γ-Aminobutyric acid-B (GABAB) receptor agonists and antagonists: pharmacological properties and therapeutic possibilities. Exp. Opin. Invest. Drugs 6, 1319–1325.
Froestl, W., Gallagher, M., Jenkins, H., et al. (2004) SGS742: the first GABAB receptor antagonist in clinical trials. Biochem. Pharmacol. 68, 1479–1487.
Guarnaccia, J. B., Bollmer, T. L., and Waxman, S. G. (1998) Multiple sclerosis, in Pharmacological Management of Neurological and Psychiatric Disorders, (Enna, S. J. and Coyle, J. T., eds.), McGraw-Hill, New York, pp. 377–428.
Mondadori, C., Preiswerk, G., and Jaekel, J. (1992) Treatment with a GABAB receptor blocker improves the cognitive performance of mice, rats and rhesus monkeys. Pharmacol. Comm. 2, 93–97.
DeSousa, N. J., Benninger, R., Jhamandas, K., and Boegman, R. J. (1994) Stimulation of GABAB receptors in the basal forebrain selectively impairs working memory of rats in the double Y-maze. Brain Res. 641, 29–38.
Snead, O. C. (1995) Basic mechanisms of generalized absence epilepsy. Ann. Neurol. 37, 146–157.
Corrigall, W. A., Coen, K. M., Adamson, K. L., Chow, B. L., and Zhang, J. (2000) Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology 149, 107–114.
Haney, M., Hart, C. L., and Foltin, R. W. (2006) Effects of baclofen on cocaine self-administration: opioid-and nonopioid-dependent volunteers. Neuropsychopharmacology 31, 1814–1821.
Flannery, B. A., Garbutt, J. C., Cody, M. W., et al. (2004) Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin. Exp. Res. 28, 1517–1523.
Queva, C., Bremner-Danielsen, M., Edlund, A., et al. (2003) Effects of GABA agonists on body temperature regulation in GABA(B(1))-/-mice. Br. J. Pharmacol. 140, 315–322.
Thuault, S. J., Brown, J. T., Sheardown, S. A., et al. (2004) The GABAB2 subunit is critical for the trafficking and function of native GABAB receptors. Biochem. Pharmacol. 68, 1655–1666.
Getova, D. P., Bowery, N. G., and Spassov, V. (1997) Effects of GABAB receptor antagonists on learning and memory retention in a rat model of absence epilepsy. Eur. J. Pharmacol. 320, 9–13.
Hosford, D. A., Wang, Y., Liu, C. C., and Snead, O. C. (1995) Characterization of the antiabsence effects of SCH 50911, a GABA-B receptor antagonist, in the lethargic mouse, gamma-hydroxybutyrate, and pentylenetetrazole models. J. Pharmacol. Exp. Ther. 274, 1399–1403.
Vergnes, M., Boehrer, A., Simler, S., Bernasconi, R., and Marescaux, C. (1997) Opposite effects of GABAB receptor antagonists on absences and convulsive seizures. Eur. J. Pharmacol. 332, 245–255.
Badran, S., Schmutz, M., and Olpe, H. R. (1997) Comparative in vivo and in vitro studies with the potent GABAB receptor antagonist, CGP 56999A. Eur. J. Pharmacol. 333, 135–142.
Nakagawa, Y., Sasaki, A., and Takashima, T. (1999) The GABA(B) receptor antagonist CGP36742 improves learned helplessness in rats. Eur. J. Pharmacol. 381, 1–7.
Heese, K., Otten, U., Mathivet, P., Raiteri, M., Marescaux, C., and Bernasconi, R. (2003) GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. Neuropharmacology 39, 449–462.
Mombereau, C., Kaupmann, K., Froestl, W., Sansig, G., van der Putten, H., and Cryan, J. F. (2004) Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety-and antidepressant-like behavior. Neuropsychopharmacology 29, 1050–1062.
Vaught, J. L., Pelly, K., Costa, L. G., Settler, P., and Enna, S. J. (1985) A comparison of the antinociceptive responses to the GABA receptor agonists THIP and baclofen. Neuropharmacology 24, 211–216.
Smith, G. D., Harrison, S. M., Birch, P. J., Elliott, P. J., Malcangio, M., and Bowery, N. G. (1994) Increased sensitivity to the antinociceptive activity of (±)-baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia. Neuropharmacology 33, 1103–1108.
Fromm, G. (1994) Baclofen as an adjuvant analgesic. J. Pain Symptom Manage. 9, 500–509.
Roberts, E. and Frankel, S. (1950) Gamma-aminobutyric acid in brain: its formation from glutamic acid. J. Biol. Chem. 187, 55–63.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Enna, S.J. (2007). The GABA Receptors. In: Enna, S.J., Möhler, H. (eds) The GABA Receptors. The Receptors. Humana Press. https://doi.org/10.1007/978-1-59745-465-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-59745-465-0_1
Publisher Name: Humana Press
Print ISBN: 978-1-58829-813-3
Online ISBN: 978-1-59745-465-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)